Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska
Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska
Use the TB Medication Dose Monitoring forms to help count each DOT dose. Regimen Two (2) is often used in Alaska. Forms to assist in counting drugs for all four regimens can be found in the Forms section of this manual 18.1. Contact the Alaska TB Program at 907-269-8000 to determine the end of treatment date based upon the number of DOT doses consumed during the number of weeks of treatment. If unable to locate a patient despite many attempts, call the Alaska TB Program at 907-269-8000 to review the case. Documenting Completion of Treatment and Follow-up Recommendations The case manager should insure that the patient understands when TB treatment is complete and provide written documentation to the patient of an adequate course of treatment. General and individualized specific follow-up recommendations should also be provided in writing to the patient. All individuals completing treatment for active tuberculosis should also be educated about the symptoms of tuberculosis and be advised to be re-evaluated should they occur in the future. Use the End of Treatment Letter and Summary to provide written TB treatment and follow-up information to the patient. It can be found in the Forms section of this manual 18.1. A L A S K A T B P R O G R A M M A N U A L Case Management 10. 30 R e v i s e d N o v e m b e r 2 0 1 2
Case Closures Other than Completion of Therapy Moved: All attempts should be made by the case manager to obtain the new or forwarding address. If this new address is within the original jurisdiction, the case should be transferred, as per the local public health agency protocol. If the new address is in another jurisdiction, the Alaska TB Program should be notified and procedures followed as described in the Transfer Notifications section. Cases should be closed as “moved” only if a new address is obtained. For information on who to alert when a case will move or has moved, refer to the Transfer Notifications section 15.1. Not TB: If the completed diagnostic evaluation determined that the diagnosis of TB is not substantiated and another diagnosis is established, the case is closed as “Not TB.” If unable to locate a patient despite many attempts, call the Alaska TB Program at 907-269-8000 to review the case. Died: If the patient expired prior to completion of therapy, the case is closed as “Died.” 62 Ensure that the contact investigation on the case is also completed. For more information, see the Contact Investigation section 11.1. A L A S K A T B P R O G R A M M A N U A L Case Management 10. 31 R e v i s e d N o v e m b e r 2 0 1 2
- Page 197 and 198: For consultation regarding the trea
- Page 199 and 200: Monitoring DOT is mandatory for INH
- Page 201 and 202: For young infants, some experts rec
- Page 203 and 204: TABLE 8: SIGNS AND SYMPTOMS OF PULM
- Page 205 and 206: Treatment of Tuberculosis Basic pri
- Page 207 and 208: Regime n 1 2 3 ❺ Table 10: FOUR T
- Page 209 and 210: † 35 Table 11: DOSES*OF FIRST-LIN
- Page 211 and 212: Monitoring Response to Treatment Ch
- Page 213 and 214: Child Care and Schools: Children wi
- Page 215 and 216: Other TB medications are not commer
- Page 217 and 218: 10 Centers for Disease Control and
- Page 219 and 220: Case Management CONTENTS Introducti
- Page 221 and 222: patient-centered approach to case m
- Page 223 and 224: Alaska TB Program: Timeline for the
- Page 225 and 226: For assistance with language issues
- Page 227 and 228: Ascertain the extent of TB illness
- Page 229 and 230: medical/health problem. The date of
- Page 231 and 232: necessary to teach people how to ta
- Page 233 and 234: Treatment Plan Components Recommend
- Page 235 and 236: Implementation Activities To begin
- Page 237 and 238: o Indicate the number of doses prov
- Page 239 and 240: Review the status of the contact in
- Page 241 and 242: For more information, see the “Di
- Page 243 and 244: importance of continued treatment a
- Page 245 and 246: 5. Review information with the prov
- Page 247: Completion of Therapy The case mana
- Page 251 and 252: Conduct a case management meeting o
- Page 253 and 254: Biweekly (BIW) doses of TB medicati
- Page 255 and 256: Use DOT with other measures such as
- Page 257 and 258: It is important not to send a mixed
- Page 259 and 260: Medical Orders Progressive Interven
- Page 261 and 262: CDC. Module 9: “Patient Adherence
- Page 263 and 264: 36 New Jersey Medical School Nation
- Page 265 and 266: 75 CDC. Module 9: patient adherence
- Page 267 and 268: Introduction Purpose A contact inve
- Page 269 and 270: For roles and responsibilities, ref
- Page 271 and 272: Decision to Initiate a Contact Inve
- Page 273 and 274: chest radiographic findings that ar
- Page 275 and 276: In general, a contact investigation
- Page 277 and 278: Time Frames for Contact Investigati
- Page 279 and 280: Circumstances unique to Alaska may
- Page 281 and 282: Circumstances unique to Alaska may
- Page 283 and 284: Activity Purpose Maximum Time Inter
- Page 285 and 286: Infectious Period Determine the inf
- Page 287 and 288: In general, for the purposes of con
- Page 289 and 290: General Guidelines for Interviewing
- Page 291 and 292: Healthcare workers should remember
- Page 293 and 294: Index Patient with Positive Acid-Fa
- Page 295 and 296: Index Patient with Negative Acid-Fa
- Page 297 and 298: Contact Evaluation, Treatment, and
Use the TB Medication Dose Monitoring forms to help count each DOT<br />
dose. Regimen Two (2) is <strong>of</strong>ten used in <strong>Alaska</strong>. Forms to assist in<br />
counting drugs for all four regimens can be found in the Forms section <strong>of</strong><br />
this manual 18.1.<br />
Contact the <strong>Alaska</strong> TB <strong>Program</strong> at 907-269-8000 to determine the end <strong>of</strong><br />
treatment date based upon the number <strong>of</strong> DOT doses consumed during<br />
the number <strong>of</strong> weeks <strong>of</strong> treatment.<br />
If unable to locate a patient despite many attempts, call the <strong>Alaska</strong> TB<br />
<strong>Program</strong> at 907-269-8000 to review the case.<br />
Documenting Completion <strong>of</strong> Treatment and Follow-up<br />
Recommendations<br />
The case manager should insure that the patient understands when TB treatment is<br />
complete and provide written documentation to the patient <strong>of</strong> an adequate course <strong>of</strong><br />
treatment. General and individualized specific follow-up recommendations should also<br />
be provided in writing to the patient. All individuals completing treatment for active<br />
tuberculosis should also be educated about the symptoms <strong>of</strong> tuberculosis and be<br />
advised to be re-evaluated should they occur in the future.<br />
Use the End <strong>of</strong> Treatment Letter and Summary to provide written TB<br />
treatment and follow-up information to the patient. It can be found in the<br />
Forms section <strong>of</strong> this manual 18.1.<br />
A L A S K A T B P R O G R A M M A N U A L Case Management 10. 30<br />
R e v i s e d N o v e m b e r 2 0 1 2